Alphamab Oncology Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 5/6
Alphamab Oncology has a total shareholder equity of CN¥1.6B and total debt of CN¥320.0M, which brings its debt-to-equity ratio to 19.6%. Its total assets and total liabilities are CN¥2.1B and CN¥513.3M respectively.
Anahtar bilgiler
19.6%
Borç/özkaynak oranı
CN¥320.00m
Borç
Faiz karşılama oranı | n/a |
Nakit | CN¥1.46b |
Eşitlik | CN¥1.63b |
Toplam yükümlülükler | CN¥513.25m |
Toplam varlıklar | CN¥2.14b |
Son finansal sağlık güncellemeleri
Is Alphamab Oncology (HKG:9966) Using Debt Sensibly?
Oct 04Is Alphamab Oncology (HKG:9966) A Risky Investment?
May 21Rock star Growth Puts Alphamab Oncology (HKG:9966) In A Position To Use Debt
Oct 05Is Alphamab Oncology (HKG:9966) Using Too Much Debt?
May 05Recent updates
Alphamab Oncology (HKG:9966) Stocks Shoot Up 91% But Its P/S Still Looks Reasonable
Sep 30Some Alphamab Oncology (HKG:9966) Shareholders Look For Exit As Shares Take 48% Pounding
Jun 20Alphamab Oncology's (HKG:9966) Shares Climb 27% But Its Business Is Yet to Catch Up
May 06Optimistic Investors Push Alphamab Oncology (HKG:9966) Shares Up 27% But Growth Is Lacking
Mar 13Subdued Growth No Barrier To Alphamab Oncology's (HKG:9966) Price
Jan 17Slammed 40% Alphamab Oncology (HKG:9966) Screens Well Here But There Might Be A Catch
May 21Newsflash: Alphamab Oncology (HKG:9966) Analysts Have Been Trimming Their Revenue Forecasts
Mar 01Is Alphamab Oncology (HKG:9966) Using Debt Sensibly?
Oct 04Is Alphamab Oncology (HKG:9966) A Risky Investment?
May 21Rock star Growth Puts Alphamab Oncology (HKG:9966) In A Position To Use Debt
Oct 05Is Alphamab Oncology (HKG:9966) Using Too Much Debt?
May 05Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: 9966's short term assets (CN¥1.6B) exceed its short term liabilities (CN¥345.4M).
Uzun Vadeli Yükümlülükler: 9966's short term assets (CN¥1.6B) exceed its long term liabilities (CN¥167.9M).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: 9966 has more cash than its total debt.
Borcun Azaltılması: 9966 had negative shareholder equity 5 years ago, but is now positive and has therefore improved.
Bilanço
Nakit Pist Analizi
Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.
İstikrarlı Nakit Pisti: 9966 has sufficient cash runway for more than 3 years based on its current free cash flow.
Tahmini Nakit Akışı: Insufficient data to determine if 9966 has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.